Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark J. Ahn currently holds 493,182 shares of RXI PHARMACEUTICALS CORP (RXII), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark J. Ahn has been a net seller of RXII stock. They have purchased $276.6K and sold $3.8M worth of shares.
Mark J. Ahn's most recent insider trade was on Nov 8, 2016, when they sold 150,000 shares at $2.31 per share.
Mark J. Ahn serves as Executive at RXI PHARMACEUTICALS CORP (RXII). They have executed 29 insider transactions totaling $4.1M over their tenure at the company.
Mark J. Ahn holds the position of Executive at RXI PHARMACEUTICALS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Mark J. Ahn has shown a selling trading pattern, with $276.6K in total purchases and $3.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark J. Ahn was on Jan 27, 2014, when they sold $3.8M worth of GALE shares. This transaction involved 796,765 shares at $4.83 per share.
Mark J. Ahn currently owns 493,182 shares of RXI PHARMACEUTICALS CORP (RXII), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark J. Ahn's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark J. Ahn has 29 Form 4 filings on record as an insider at RXI PHARMACEUTICALS CORP.
Set alerts for Mark J. Ahn and 40,000+ other insiders.